Antares Pharma, Inc. (ATRS) Social Stream
Antares Pharma Inc (ATRS) Price Targets From Analysts
Use the tables below to see what analysts covering Antares Pharma Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
ATRS's average price target has moved down $0 over the prior 39 weeks.
Over the past 47 weeks, ATRS's average upside potential has been 69.38%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ATRS Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 35 weeks, ATRS's average broker recommendation rating improved by 0.5.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ATRS as an investment opportunity.
- ATRS has a greater average analyst price target than 18.26% of all US stocks.
- Antares Pharma Inc's number of analysts covering the stock is greater than 306.03% of stocks in the small market cap category.
- In terms of how Antares Pharma Inc fares relative to Healthcare stocks, note that its upside potential (average analyst target price relative to current price) is greater than 139.85% of that group.
- ATRS has a lower variance in analysts' estimates than -56.95% of Healthcare stocks.
What is the outlook for ATRS? Use POWR Ratings for clearer insight into price direction.